You need both pieces of information
When Cannabis Use May Require Extra Caution Before GLP-1 Therapy Cannabis use may require extra caution when symptoms already involve vomiting, poor intake, sedation, abnormal digestion, or blood sugar risk
Tirzepatide maintenance: the SURMOUNT-4 evidence The SURMOUNT-4 trial used a randomized-withdrawal design: all participants took open-label tirzepatide for 36 weeks (reaching a mean weight reduction of about 20.9%), then were randomized either to continue the drug or switch to placebo for another 52 weeks
GLP-1 receptor agonists are highly effective medications that mimic the GLP-1 hormone to regulate blood sugar, slow gastric emptying, and increase satiety
Identifying risk factors, such as pre-existing conditions, will help you determine if you are more susceptible to back pain while taking semaglutide